(Updated - July 8, 2024 10:20 AM EDT)

UBS analyst Jo Walton downgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE